Preemptive oral ganciclovir therapy versus prophylaxis to prevent symptomatic cytomegalovirus infection after kidney transplantation

Transplant Proc. 2001 Nov-Dec;33(7-8):3621-3. doi: 10.1016/s0041-1345(01)02558-1.
No abstract available

Publication types

  • Clinical Trial
  • Comparative Study
  • Randomized Controlled Trial

MeSH terms

  • Administration, Oral
  • Antiviral Agents / economics
  • Antiviral Agents / therapeutic use*
  • Costs and Cost Analysis
  • Cytomegalovirus Infections / economics
  • Cytomegalovirus Infections / epidemiology
  • Cytomegalovirus Infections / prevention & control*
  • Ganciclovir / economics
  • Ganciclovir / therapeutic use*
  • Germany
  • Humans
  • Kidney Transplantation / physiology*
  • Postoperative Complications / prevention & control*
  • Postoperative Complications / virology

Substances

  • Antiviral Agents
  • Ganciclovir